Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of May 2016. The report addresses corporate governance matters regarding shareholder meetings rather than financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to procedural updates regarding shareholder meetings.
Material Changes
No material financial changes are reported. The primary event is the adjournment of two special meetings originally scheduled for May 30, 2016, due to a lack of quorum.
Guidance, Outlook, and Management Commentary
Management has announced the rescheduling of the following meetings to Monday, June 6, 2016, at the company's offices in Petach Tikva, Israel:
- Special General Meeting of Shareholders: 4:00 p.m. (Israel time).
- Special General Meeting of Series 11 Warrant Holders: 4:30 p.m. (Israel time).
The filing incorporates by reference into the company's Registration Statements on Form F-3.
Key Facts for Investor Verification
- Verify the agenda and voting outcomes of the reconvened meetings on June 6, 2016.
- Confirm the specific resolutions intended for the Series 11 Warrant Holders.
- Check subsequent filings for the financial results that were not included in this procedural report.